Evidence for
The 2021 Chinese Swimmers’ Trimetazidine Positives and WADA’s Contamination Decision

Companion notes

Chinese swimmers’ positive trimetazidine tests and WADA’s contamination finding

The official record establishes that 23 Chinese swimmers were later reported by WADA to have registered trimetazidine positives from urine collected at a January 2021 national meet, and that CHINADA treated the matter as a contamination case. WADA’s public account says it reviewed that explanation, could not disprove it, and later faced an independent review that found no evidence of favoritism or interference.

The Paper Trail & Official Records

The documentary trail begins with CHINADA’s collection of 60 urine samples from Chinese swimmers at a national meet between 1 and 3 January 2021, followed by laboratory processing and later entry into WADA’s ADAMS system. WADA’s own public fact sheet and later institutional summaries describe 28 adverse analytical findings for trimetazidine among 23 swimmers, tying the case to the early-2021 sample set rather than to a separate later event. Contemporary reporting in 2024 revived the file by quoting WADA’s account and the institutional chronology already on record. [S2], [S3], [S5]

The key records are not court filings or indictments, but anti-doping agency materials, published explanatory statements, and independent journalistic coverage of those statements. CHINADA’s handling is central because it was the national anti-doping authority that first received the results, investigated the source of TMZ, and ultimately accepted a contamination explanation. WADA’s archived materials, paired with BBC and ABC reporting, are the clearest public documentary sources for reconstructing how the case was processed administratively. [S2], [S3], [S4], [S5]

Forensic Chronology & Turning Points

The timeline shows a sequence, not a single ruling. First came sample collection in early January 2021; then, after COVID-19-related delay, the results were entered into the anti-doping database on 15 March 2021. In April, CHINADA told WADA it had opened an investigation and involved public health authorities. By June, WADA said CHINADA had accepted contamination as the explanation and that WADA had reviewed that decision rather than overturning it. [S3], [S5]

The decisive turning point was WADA’s own explanation that it could not disprove contamination after reviewing the case file, consulting independent scientific experts, and obtaining outside legal advice. WADA also said its investigators could not travel to China because of COVID-19 restrictions, a procedural constraint that shaped the review but did not itself resolve the science. The later 2024 public reporting did not add new testing data; it surfaced the earlier agency narrative and the controversy around it. [S4], [S5]

Evidentiary Boundaries & Negative Findings

What the record establishes is narrower than the public debate sometimes suggests. It establishes reported trimetazidine positives, CHINADA’s contamination conclusion, and WADA’s statement that it was not in a position to disprove that explanation. It does not, on the materials reviewed here, establish intentional doping by the swimmers. It also does not show that WADA independently adjudicated guilt or innocence in a tribunal-like proceeding; rather, it reviewed CHINADA’s handling and articulated its own fault/no-fault position. [S3], [S5]

Nor do the records support a proven cover-up. Swiss prosecutor Eric Cottier’s independent review found no evidence that WADA showed favoritism or interfered in the matter, and BBC reporting on that finding aligns with the broader institutional record. The strongest negative finding, therefore, is evidentiary: the case remains bounded by agency conclusions, investigative limitations, and a contamination explanation that WADA said it could not refute. That leaves serious questions of judgment and process, but not a documented finding of conspiracy or intentional concealment. [S1], [S4]

Source key

The associated evidence packet contains visible source URLs, source roles and the complete claim ledger.